Blueprint studio · Spec sheets · Amber callouts · Free shipping over $75

myminiwebpage.com Blueprint · Rev.39

Sheet A · Product board

ghk-cu cream Private Label Copper Tripeptide-1 Face Size:50 ml free from:Corn SOL Rejuvenation - Medical including sensitive skin.

Unit price

USD22.65

USD68.65

Pay in 4 interest-free payments of $5.66 Learn more

Field rating

4.6

Verified studio score · Spec revision current

Fit · Size

ghk-cu cream

ghk-cu cream Private Label Copper Tripeptide-1 Face Size:50 ml free from:Corn SOL Rejuvenation - Medical including sensitive skin.

SKU: 56482375765

Dispatch

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 19 - Oct 24

Description

ghk-cu cream Private Label Copper Tripeptide-1 Face Size:50 ml free from:Corn SOL Rejuvenation - Medical including sensitive skin.

SOL Rejuvenation - Medical Aesthetics & Wellness (@sol.rejuvenation.nh) • Facebook

doi:10.1023/A:1023768811842

free from:Corn

Size:50 ml

Kaczmarek M, Lagiedo M, Masztalerz A, Kozlowska M, Nowicka A, Brajer B, Batura-Gabryel H, Sikora J

including sensitive skin.

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI

US$ 26.78

4.5 (23 reviews)

Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells

Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells

US$ 20.70

4.4 (19 reviews)

Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment

Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment

US$ 25.31

4.9 (27 reviews)

FOXO4-DRI causes nuclear exclusion of active p53 and induces apoptosis

FOXO4-DRI causes nuclear exclusion of active p53 and induces apoptosis

US$ 27.59

4.3 (7 reviews)

foxo4-dri human trial FOXO4-DRI: The Senolytic Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness FOXO4-DRI improves spermatogenesis in aged –

foxo4-dri human trial FOXO4-DRI: The Senolytic Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness FOXO4-DRI improves spermatogenesis in aged –

US$ 21.72

4.3 (17 reviews)

FOXO4-DRI: Senolytic Peptide Design and Handling

FOXO4-DRI: Senolytic Peptide Design and Handling

US$ 24.39

4.9 (13 reviews)

foxo4-dri p53 human trials senolytic peptide trial regulates endothelial cell senescence via the signaling pathway FOXO4-DRI 10mg vial FOXO4-DRI improves spermatogenesis in aged – FOXO4-DRI Research Material

foxo4-dri p53 human trials senolytic peptide trial regulates endothelial cell senescence via the signaling pathway FOXO4-DRI 10mg vial FOXO4-DRI improves spermatogenesis in aged – FOXO4-DRI Research Material

US$ 21.84

4.2 (24 reviews)

FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway

FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway

US$ 22.40

4.1 (17 reviews)

foxo4-dri peptide senolytic 2023 2024 study FOXO4-DRI induces keloid senescent fibroblast –

foxo4-dri peptide senolytic 2023 2024 study FOXO4-DRI induces keloid senescent fibroblast –

US$ 29.03

4.1 (11 reviews)

Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis

Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis

US$ 26.91

4.6 (16 reviews)

PDF) Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes

PDF) Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes

US$ 25.40

4.1 (13 reviews)

FOXO4-DRI

US$ 28.76

4.5 (12 reviews)

foxo4-dri senolytic peptide human trial regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI 10mg vial foxo4-dri peptide senolytic study foxo4 –

foxo4-dri senolytic peptide human trial regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI 10mg vial foxo4-dri peptide senolytic study foxo4 –

US$ 20.89

4.9 (21 reviews)

Frontiers

Frontiers

US$ 29.19

4.9 (15 reviews)

Buy FOXO4-DRI Belgium PharmaGrade.Store

Buy FOXO4-DRI Belgium PharmaGrade.Store

US$ 26.38

4.3 (21 reviews)

foxo4-dri senolytic 2023 2024 study improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells Full article: Targeting Cellular Senescence –

foxo4-dri senolytic 2023 2024 study improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells Full article: Targeting Cellular Senescence –

US$ 21.21

4.5 (7 reviews)

foxo4-dri senolytic 2024 human trial foxo4 dri trials FOXO4-DRI: The Peptide That Targets Zombie foxo4-dri senolytic peptide human trial –

foxo4-dri senolytic 2024 human trial foxo4 dri trials FOXO4-DRI: The Peptide That Targets Zombie foxo4-dri senolytic peptide human trial –

US$ 19.99

4.8 (26 reviews)

Frontiers

Frontiers

US$ 24.34

4.4 (22 reviews)

FOXO4-DRI UK | Senolytic Peptide Research

FOXO4-DRI UK | Senolytic Peptide Research

US$ 26.94

4.7 (6 reviews)

foxo4-dri senolytic 2023 2024 study CHK2-USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis GET RID OF ZOMBIE CELLS –

foxo4-dri senolytic 2023 2024 study CHK2-USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis GET RID OF ZOMBIE CELLS –

US$ 22.53

4.1 (28 reviews)